IMP
Process View
Homo sapiens
15 genes annotated in human
urinary system cancer
DOID:3996
An organ system cancer that is located in the kidneys, ureteres, bladder or urethra.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "urinary system cancer"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.309 | ||
| CUL2 | cullin 2 | 0.255 | ||
| HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.213 | ||
| TCEB2 | transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B) | 0.190 | ||
| RASSF1 | Ras association (RalGDS/AF-6) domain family member 1 | 0.167 | ||
| PALB2 | partner and localizer of BRCA2 | 0.073 | ||
| GLI1 | GLI family zinc finger 1 | 0.062 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.058 | ||
| RBM10 | RNA binding motif protein 10 | 0.052 | ||
| PRKCZ | protein kinase C, zeta | 0.047 | ||
| TCEB1 | transcription elongation factor B (SIII), polypeptide 1 (15kDa, elongin C) | 0.047 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.044 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.044 | ||
| HGF | hepatocyte growth factor (hepapoietin A; scatter factor) | 0.039 | ||
| PCBD1 | pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha | 0.039 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.036 | ||
| COMMD1 | copper metabolism (Murr1) domain containing 1 | 0.034 | ||
| PCBD2 | pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1) 2 | 0.034 | ||
| RAD51 | RAD51 homolog (RecA homolog, E. coli) (S. cerevisiae) | 0.032 | ||
| RANBP9 | RAN binding protein 9 | 0.031 | ||
| DMC1 | DMC1 dosage suppressor of mck1 homolog, meiosis-specific homologous recombination (yeast) | 0.029 | ||
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.027 | ||
| RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.027 | ||
| EGLN1 | egl nine homolog 1 (C. elegans) | 0.026 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.024 | ||
| RBX1 | ring-box 1, E3 ubiquitin protein ligase | 0.023 | ||
| CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.021 | ||
| FANCE | Fanconi anemia, complementation group E | 0.017 | ||
| FANCG | Fanconi anemia, complementation group G | 0.017 | ||
| PARD6B | par-6 partitioning defective 6 homolog beta (C. elegans) | 0.016 | ||
| FZR1 | fizzy/cell division cycle 20 related 1 (Drosophila) | 0.015 | ||
| EGFR | epidermal growth factor receptor | 0.014 | ||
| FGF1 | fibroblast growth factor 1 (acidic) | 0.014 | ||
| SYCP3 | synaptonemal complex protein 3 | 0.013 | ||
| PPIL2 | peptidylprolyl isomerase (cyclophilin)-like 2 | 0.013 | ||
| DVL3 | dishevelled, dsh homolog 3 (Drosophila) | 0.012 | ||
| GNB2L1 | guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1 | 0.012 | ||
| MRE11A | MRE11 meiotic recombination 11 homolog A (S. cerevisiae) | 0.012 | ||
| FANCD2 | Fanconi anemia, complementation group D2 | 0.012 | ||
| PLXNB1 | plexin B1 | 0.011 | ||
| EGLN3 | egl nine homolog 3 (C. elegans) | 0.011 | ||
| SAC3D1 | SAC3 domain containing 1 | 0.010 | ||
| BAG1 | BCL2-associated athanogene | 0.010 | ||
| HNF1B | HNF1 homeobox B | 0.010 | ||
| RB1 | retinoblastoma 1 | 0.010 | ||
| HNF1A | HNF1 homeobox A | 0.008 | ||
| WT1 | Wilms tumor 1 | 0.002 | ||
| RNF139 | ring finger protein 139 | 0.002 | ||
| VHL | von Hippel-Lindau tumor suppressor | 0.002 | ||
| FLCN | folliculin | 0.002 | ||
| GPC3 | glypican 3 | 0.002 | ||
| FGFR3 | fibroblast growth factor receptor 3 | 0.002 | ||
| PRCC | papillary renal cell carcinoma (translocation-associated) | 0.002 | ||
| OGG1 | 8-oxoguanine DNA glycosylase | 0.002 | ||
| KRAS | v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog | 0.002 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.001 | ||
| HRAS | v-Ha-ras Harvey rat sarcoma viral oncogene homolog | 0.001 | ||
| BRCA2 | breast cancer 2, early onset | 0.001 |